SYK and autoimmune thrombocytopenia: Notably, platelet activation via the non-receptor protein tyrosine kinase Syk has been associated with thrombo-inflammatory conditions, such as autoimmune thrombocytopenia and cerebral infarction44, and inhibition of Syk may yield novel treatment options therein45,46.